EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 -0.0788
March 31, 2026 -0.0259
December 31, 2025 -0.0304
September 30, 2025 -0.0234
June 30, 2025 -0.0255
March 31, 2025 -0.0297
December 31, 2024 -0.0174
September 30, 2024 -0.0284
June 30, 2024 -0.0858
March 31, 2024 -0.0363
December 31, 2023 -0.0236
September 30, 2023 -0.0299
June 30, 2023 -0.035
December 31, 2022 -0.286
September 30, 2022 -0.152
June 30, 2022 0.022
March 31, 2022 -0.14
December 31, 2021 -0.152
September 30, 2021 -0.018
June 30, 2021 -0.05
March 31, 2021 -0.11
December 31, 2020 -0.046
September 30, 2020 -0.012
June 30, 2020 -0.01
March 31, 2020 -0.01
Date Value
December 31, 2019 -0.008
September 30, 2019 -0.01
June 30, 2019 -0.01
March 31, 2019 -0.01
December 31, 2018 -0.008
September 30, 2018 -0.018
June 30, 2018 -0.01
March 31, 2018 -0.024
December 31, 2017 -0.02
September 30, 2017 -0.062
June 30, 2017 -0.038
March 31, 2017 -0.014
December 31, 2016 -0.004
September 30, 2016 -0.01
June 30, 2016 -0.026
March 31, 2016 3.742
December 31, 2015 -1.008
June 30, 2015 -2.00
March 31, 2015 -1.506
December 31, 2014 -2.00
September 30, 2014 -3.24
June 30, 2014 -4.00
March 31, 2014 -0.6707
December 31, 2013 -1.333
September 30, 2013 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Biotricity, Inc. -0.0463
Aclarion, Inc. -1.116
HeartFlow, Inc. -0.1822
Agilent Technologies, Inc. 1.279
Abbott Laboratories 0.5324

EPS Diluted (Quarterly) Related Metrics